Evidence map›Paper›PMID 26859298›Full record

Trial reportPloS one2016

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score.

Isabelle Bourdel-Marchasson, Abou Diallo, Carine Bellera, Christelle Blanc-Bisson, Jessica Durrieu, Christine Germain, Simone Mathoulin-Pélissier, Pierre Soubeyran, Muriel Rainfray, Mariane Fonck and 1 more

Abstract readRandomized Controlled TrialValidation Study
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Guideline
  4. Protein intake, weight loss, dietary intervention, and worsening of quality of life in older patients during chemotherapy for cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Observational
  13. Article
  14. Article
  15. Article
  16. A prospective nutritional assessment using Mini Nutritional Assessment-short form among patients with head and neck cancer receiving concurrent chemoradiotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  17. Article
  18. Impact of the antifermentative diet during radiotherapy for prostate cancer in elderly, SÃO Paulo, Brazil.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Isabelle Bourdel-MarchassonClinical Gerontology Department, CHU Bordeaux, Bordeaux, France.
Abou DialloClinical Epidemiology Unit, CHU Bordeaux, Bordeaux, France.
Carine BelleraCIC-14.01, INSERM, Bordeaux, France.
Christelle Blanc-BissonClinical Gerontology Department, CHU Bordeaux, Bordeaux, France.
Jessica DurrieuClinical Gerontology Department, CHU Bordeaux, Bordeaux, France.
Christine GermainClinical Epidemiology Unit, CHU Bordeaux, Bordeaux, France.
Simone Mathoulin-PélissierCIC-14.01, INSERM, Bordeaux, France.
Pierre SoubeyranMedical Oncology Department, Institut Bergonié, Bordeaux, France.
Muriel RainfrayClinical Gerontology Department, CHU Bordeaux, Bordeaux, France.
Mariane FonckMedical Oncology Department, Institut Bergonié, Bordeaux, France.
Adelaïde DoussauClinical Epidemiology Unit, CHU Bordeaux, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe MNA (Mini Nutritional Assessment) is known as a prognosis factor in older population. We analyzed the prognostic value for one-year mortality of MNA items in older patients with cancer treated with chemotherapy as the basis of a simplified prognostic score.

methodsThe prospective derivation cohort included 606 patients older than 70 years with an indication of chemotherapy for cancers. The endpoint to predict was one-year mortality. The 18 items of the Full MNA, age, gender, weight loss, cancer origin, TNM, performance status and lymphocyte count were considered to construct the prognostic model. MNA items were analyzed with a backward step-by-step multivariate logistic regression and other items were added in a forward step-by-step regression. External validation was performed on an independent cohort of 229 patients.

resultsAt one year 266 deaths had occurred. Decreased dietary intake (p = 0.0002), decreased protein-rich food intake (p = 0.025), 3 or more prescribed drugs (p = 0.023), calf circumference <31 cm (p = 0.0002), tumor origin (p<0.0001), metastatic status (p = 0.0007) and lymphocyte count <1500/mm3 (0.029) were found to be associated with 1-year mortality in the final model and were used to construct a prognostic score. The area under curve (AUC) of the score was 0.793, which was higher than the Full MNA AUC (0.706). The AUC of the score in validation cohort (229 subjects, 137 deaths) was 0.698.

conclusionKey predictors of one-year mortality included cancer cachexia clinical features, comorbidities, the origin and the advanced status of the tumor. The prognostic value of this model combining a subset of MNA items and cancer related items was better than the full MNA, thus providing a simple score to predict 1-year mortality in older patients with an indication of chemotherapy.

Indexed as

Nutrition AssessmentAgedAged, 80 and overCachexiaCohort StudiesFemaleFranceGeriatric AssessmentHumansLogistic ModelsMaleMultivariate AnalysisNeoplasmsNutritional StatusPrognosisProspective Studies

Identifiers

PMID26859298
PMCPMC4747505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.